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Abstract
Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices,
there are limitations to the effectiveness of treatments that include medications for this disorder.
Relapse rates are high and often those with the illness remain symptomatic and functionally impaired.
All the evidence suggests that individuals with schizophrenia do best with a combination of
pharmacological and psychosocial intervention. One psychosocial treatment that has received much
attention is cognitive behaviour therapy (CBT). This brief review will address what we know about
the use and effectiveness of CBT at all phases of schizophrenia and its strengths, weaknesses and its
future.
Introduction
Schizophreniaisamongthe mosteconomicallycostlyand
severe medical conditions. Because onset is in young
adulthood and disability can last a lifetime, this illness
creates tremendous distress, pain and impoverished
quality of life for the affected individual and their family.
These additional “costs” are not measurable in monetary
terms but provide compelling reasons for developing
treatments that alleviate such suffering. Even with best
practices, there are limitations to the effectiveness of
medications in the treatment of schizophrenia. Relapse
rates are high and some individuals remain symptomatic
and, despite treatment, functional recovery (i.e. social
relationships, making friends, finishing school, or attend-
ing work) remains a major challenge. All the evidence
suggeststhatindividualswithschizophreniadobestwitha
combination of pharmacological and psychosocial inter-
vention [1]. Thus, it is critical that we have effective
psychological treatment approaches to complement phar-
macology.Inthetreatmentofpsychiatricproblems,oneof
the most widely used and effective psychological treat-
ments iscognitivebehaviourtherapy(CBT).Traditionally,
CBT has been used to treat depression and anxiety, but
over the last twenty years it has been adapted to treat
psychosis and is gaining recognition as a potentially
effective treatment in schizophrenia at all stages of the
illness, including the pre-psychotic phase. CBT aims at
modifying the person’s non-adaptive thoughts and beliefs
in the context of a collaborative working alliance by
teaching the link between perceptions, beliefs and
emotional or behavioral reactions, questioning the
apparent evidence supporting abnormal beliefs, encoura-
ging self-monitoring of thoughts and, teaching effective
copingstrategiesfordealingwithdistressingsymptoms.In
fact, most schizophrenia treatment guidelines have
specific recommendations about including CBT as an
intervention [2-4].
However, important questions remain. The first is how
effective is CBT for psychosis. The second is that, since it
is unlikely that CBT could be implemented in regular
mental health centers, how can it be implemented so
that patients can benefit. Most work has been carried out
in academic research centers where highly trained
therapists are available. CBT was first used with
individuals who had a more chronic course of schizo-
phrenia. Later it was tested in those at their first episode,
and current research has a focus on whether CBT may be
the treatment to prevent transition from an at-risk state to
full blown psychosis.
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To date, over 30 randomized controlled trials of CBT for
schizophrenia have been published, demonstrating (on
average) moderate benefits [5]. Some of these trials did
have design problems; however, the main finding by
Wykes and colleagues was that the more rigorous the
study, the weaker the effect of CBT [5]. Though most
have used a more general CBT for psychosis model,
focusing on all positive symptoms (delusions, hallucina-
tions, thought disorder, bizarre behaviour), some have
specifically targeted a single symptom (e.g. voices, or
paranoid delusions), whereas others have still focused
on modifying other symptoms linked to schizophrenia,
namely negative symptoms (i.e. apathy, avolition,
poverty of content and thought, flat affect) [6] and
psychological distress such as depression or anxiety.
Several studies in the meta-analysis by Wykes et al. [5]
have begun to address functional outcome (that is the
ability to develop and maintain relationships and to
work or attend school) but only as a secondary outcome
to symptoms. Some excellent work has demonstrated
that CBT can be used successfully to prevent relapse [7]
and to reduce command hallucinations (i.e. hallucina-
tions that command the patient to perform certain acts),
which are among the most distressing and high-risk
symptoms, and may be dangerous to the patient and
others [8].
CBT for a first episode of psychosis
Despite advocating CBT as a valuable treatment for
young people experiencing their first episode of
psychosis [9,10], there are very few published random
clinical trials of CBT with a first episode sample. One
of the most methodologically sound and rigorous
trials, the SoCRATES trial in the UK [11-13], demon-
strated that both CBT and supportive therapy produced
improved symptoms compared with treatment as
usual. Unfortunately, this trial attempted to deliver
the treatment over a 5-week period during the acute
phase of the illness. In the acute phase it is difficult to
determine the effectiveness of CBT relative to that of
medications. Similarly, the ACE trial from Australia
[14] demonstrated that although those receiving CBT
showed more rapid improvement, this difference was
not sustained. However, a group trial comparing CBT
for psychosis with social skills training for symptom
management and with a wait-list control for indivi-
duals with early psychosis discharged from the hospital
did demonstrate superior improvements for CBT on
overall symptoms, as well as on self-esteem, coping
strategies and social support [15]. This suggests that,
possibly with these young patients, a group format
m a yb em o r ee f f e c t i v e .
CBT in the pre-psychotic or prodromal phase
of the illness
A large body of recent research has identified individuals
who may be at risk for psychosis [16] based on the
presence of attenuated psychotic symptoms that are
often accompanied by a significant decline in social
functioning. There are concerns with using medications
in this young group, which make a case for CBT as a
treatment for emergent psychotic symptoms as a more
acceptable, and presumably safer, first step in preventive
intervention. Thus, it is possible that CBT might reduce
or avoid the need for drug treatment [17]. Although CBT
seems a logical treatment for those at clinical high risk of
developing psychosis, there are actually very few studies
examining its effectiveness. Early studies had the goal of
using CBT to prevent conversion to a full-blown
psychotic illness, but later studies began to focus on
improving the presenting symptoms and poor functional
outcome. In all current studies to date, both the CBT and
the control treatment groups appeared to demonstrate
some improvement in symptoms. Although the control
group also improved, the EDIE trial in Manchester did
demonstrate that CBT was effective in reducing conver-
sion [18]. However, the German Network study [19]
reported improvement in both groups in terms of social
functioning. The ADAPT trial in Canada was the first to
compare two psychological treatments, but the number
of conversions was very low [20] and both groups
improved. These results have been replicated in recent
trials from Australia [21,22]. Overall interpretation of
effectiveness of CBT is difficult in these groups as there
are some unique issues studying CBT with this popula-
tion. Firstly, the number of trials is limited and secondly,
the numbers converting are low at times and thus many
studies are underpowered.
More questions than answers?
Several issues remain unanswered. First, in examining
current studies, CBT seems to offer better results when it is
offered at specific stages of recovery and when the
treatment delivery is adjusted to the stage. For instance,
acutepsychosisisnotidealforself-reflection,butfollowing
stabilization, individuals with early psychosis might
benefit more – initially from group CBT that could help
normalize their experience by meeting peers with similar
issues [23]. Multiple studies have shown that individuals
with more experience with the illness, and who have some
degree of realization of their goals and problems, will
benefit from individual CBT for psychosis. Older indivi-
duals with stabilized psychotic symptoms, who are more
likely to be socially isolated with few goal-oriented
activities, appear to benefit from a group approach
integrating CBT principles with social skills training [24].
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effective or not, but rather when should it be offered, to
who, and which modality.
In terms of who should receive CBT for psychosis,
currently, it seems to be somewhat random for those
who have the opportunity. Yet toobtain resultsabove and
beyondwhat,for example,supportivetherapycould offer,
a certain level of cognitive functioning (memory, atten-
tion, problem solving) and of social cognitive functioning
(insight, emotion recognition) might be necessary. In
terms of modalities, even within the individual and group
approaches, several variants exist, making study compar-
isons at times difficult. Even though most CBT therapists
agree on the essential elements that should be included in
CBT for psychosis [25], there are a range of treatment
manuals available with a variety of techniques and
philosophies. For instance, some might be more goal-
oriented, whereas others might be problem-focused.
Individual formulation (i.e. developing a shared compre-
hension of the person’s cognitive biases and problems
based on their past experiences) is the basis for some CBT
therapists, but not for all. Furthermore, there are no
guidelines as to what may be an adequate dose of CBT.
Many studies offer over 9 months of weekly sessions,
whereas others offer a few months. In some studies it has
been suggested that those in the CBT groups did not
receive an adequate dose of CBT [20].
Finally, the ability to deliver in the real world is a
concern. The majority of the trials have been conducted
in controlled settings, using highly trained expert CBT
therapists. There is emerging evidence suggesting the
effectiveness of CBT using “non-expert” CBT therapists,
for example, psychiatrists [26], community nurses [27],
or other mental health professionals [15]. Given the
paucity of expert CBT therapists in many mental health
settings, training and supervising non-experts in deliver-
ing the intervention, albeit perhaps using a structured
manual, could be a viable option [28].
What next?
There appears to be a need for a typology of CBT
approaches and modalities used in studies, in order to
ensure replicability of the results by clinicians in real-
world settings. CBT for psychosis is currently being
adapted according to recovery stages and treatment
needs. As such, studies underway are investigating
combining CBT with other evidence-based approaches
such as supported employment, family psychoeducation,
motivational interviewing, social skills training, and third-
wave cognitive behaviour therapies, such as acceptance
and commitment therapy. More studies are warranted in
order to better understand the best moment to offer CBT
forpsychosis,towhom,andusingwhichmodality.Several
“CBT for psychosis” researchers are also investigating
process issuesin real-world settings, and will perhaps help
usunderstandwhichaspectsofthetreatmentareessential.
Overall, little is known about the moderators of CBT for
psychosis, i.e. for whom or under which conditions CBT
may work or about the mediators, that is, how CBT might
achieve its effects. Baseline patient characteristics, such as
cognitive functioning, provide valuable information to
helpidentifywhichpatientsmightberesponsivetoagiven
treatment.Understandingthe mechanisms through which
treatments work is likely to lead to more effective
therapies. To date, there is no single treatment (including
medication) for schizophrenia that helps 100% of those
receiving it. In the meantime, CBT for psychosis helps
many, and has no documented side-effects.
Abbreviation
CBT, cognitive behaviour therapy.
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